XML 26 R15.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock Compensation
3 Months Ended
Apr. 02, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Compensation
Stock compensation
The Company uses various equity-based compensation programs to provide long-term performance incentives for its global workforce. Currently, these incentives consist principally of stock options, restricted stock units, and to a lesser extent, executive performance shares and restricted stock grants. The Company also sponsors a discounted stock purchase plan in the United States and matching-grant programs in several international locations. Additionally, the Company awards restricted stock to its outside directors. The interim information below should be read in conjunction with the disclosures included within the stock compensation footnote of the Company’s 2015 Annual Report on Form 10-K.
The Company classifies pre-tax stock compensation expense in SGA expense principally within its corporate operations. For the periods presented, compensation expense for all types of equity-based programs and the related income tax benefit recognized was as follows:
 
Quarter ended
(millions)
April 2, 2016
April 4, 2015
Pre-tax compensation expense
$
16

$
12

Related income tax benefit
$
6

$
4


As of April 2, 2016, total stock-based compensation cost related to non-vested awards not yet recognized was $133 million and the weighted-average period over which this amount is expected to be recognized was 2 years.
Stock options
During the quarters ended April 2, 2016 and April 4, 2015, the Company granted non-qualified stock options to eligible employees as presented in the following activity tables. Terms of these grants and the Company’s methods for determining grant-date fair value of the awards were consistent with that described within the stock compensation footnote in the Company’s 2015 Annual Report on Form 10-K.
Quarter ended April 2, 2016:
 
Employee and director stock options
Shares (millions)
Weighted-
average
exercise price
Weighted-
average
remaining
contractual term (yrs.)
Aggregate
intrinsic
value (millions)
 
 
Outstanding, beginning of period
19

$
58

 
 
 
Granted
3

76

 
 
 
Exercised
(3
)
55

 
 
 
Forfeitures and expirations


 
 
 
Outstanding, end of period
19

$
61

7.4
$
306

 
Exercisable, end of period
12

$
57

6.4
$
242


Quarter ended April 4, 2015:
 
Employee and director stock options
Shares (millions)
Weighted-
average
exercise price
Weighted-
average
remaining
contractual term (yrs.)
Aggregate
intrinsic
value (millions)
 
 
Outstanding, beginning of period
21

$
56

 
 
 
Granted
3

64

 
 
 
Exercised
(1
)
52

 
 
 
Forfeitures and expirations


 
 
 
Outstanding, end of period
23

$
57

7.4
$
204

 
Exercisable, end of period
14

$
55

6.3
$
163



The weighted-average fair value of options granted was $9.45 per share and $7.20 per share for the quarters ended April 2, 2016 and April 4, 2015, respectively. The fair value was estimated using the following assumptions:
 
Weighted-
average
expected
volatility
Weighted-
average
expected
term
(years)
Weighted-
average
risk-free
interest
rate
Dividend
yield
Grants within the quarter ended April 2, 2016:
17
%
6.9
1.60
%
2.60
%
Grants within the quarter ended April 4, 2015:
16
%
6.9
1.98
%
3.00
%

The total intrinsic value of options exercised was $50 million and $17 million for the quarters ended April 2, 2016 and April 4, 2015, respectively.
Performance shares
In the first quarter of 2016, the Company granted performance shares to a limited number of senior executive-level employees, which entitle these employees to receive a specified number of shares of the Company’s common stock upon vesting. The number of shares earned could range between 0 and 200% of the target amount depending upon performance achieved over the three year vesting period. The performance conditions of the award include three-year currency-neutral comparable operating profit growth and total shareholder return (TSR) of the Company’s common stock relative to a select group of peer companies.
A Monte Carlo valuation model was used to determine the fair value of the awards. The TSR performance metric is a market condition. Therefore, compensation cost of the TSR condition is fixed at the measurement date and is not revised based on actual performance. The TSR metric was valued as a multiplier of possible levels of comparable operating profit growth achievement. Compensation cost related to comparable operating profit growth performance is revised for changes in the expected outcome. The 2016 target grant currently corresponds to approximately 195,000 shares, with a grant-date fair value of $76 per share.
Based on the market price of the Company’s common stock at April 2, 2016, the maximum future value that could be awarded to employees on the vesting date for all outstanding performance share awards was as follows:
(millions)
April 2, 2016
2014 Award
$
31

2015 Award
$
27

2016 Award
$
30


The 2013 performance share award, payable in stock, was settled at 35% of target in February 2016 for a total dollar equivalent of $3 million.
Other stock-based awards
During the quarter ended April 2, 2016, the Company granted restricted stock units and a nominal number of restricted stock awards to eligible employees as presented in the following table. Terms of these grants and the Company’s method of determining grant-date fair value were consistent with that described within the stock compensation footnote in the Company’s 2015 Annual Report on Form 10-K.
Quarter ended April 2, 2016:
Employee restricted stock and restricted stock units
Shares(thousands)
Weighted-average grant-date fair value
Non-vested, beginning of year
806

$
58

Granted
547

70

Vested
(47
)
55

Forfeited
(15
)
56

Non-vested, end of period
1,291

$
63


Quarter ended April 4, 2015:
Employee restricted stock and restricted stock units
Shares(thousands)
Weighted-average grant-date fair value
Non-vested, beginning of year
346

$
54

Granted
563

58

Vested
(48
)
51

Forfeited
(2
)
58

Non-vested, end of period
859

$
57